Kandaswamy Vijayan
Directeur Général chez Zafrens, Inc.
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Michael Grey | M | 71 |
Plexium, Inc.
Plexium, Inc. Pharmaceuticals: MajorHealth Technology Plexium, Inc. provides drug development methodology services. It specializes in immunomodulation as a therapeutic approach for CNS and oncology. The company was founded by Brian Paegel on July 12, 2017 and is headquartered in San Diego, CA. | 4 ans |
Robert Hopfner | M | 51 |
Plexium, Inc.
Plexium, Inc. Pharmaceuticals: MajorHealth Technology Plexium, Inc. provides drug development methodology services. It specializes in immunomodulation as a therapeutic approach for CNS and oncology. The company was founded by Brian Paegel on July 12, 2017 and is headquartered in San Diego, CA. | 3 ans |
Adam Goulburn | M | 42 |
Plexium, Inc.
Plexium, Inc. Pharmaceuticals: MajorHealth Technology Plexium, Inc. provides drug development methodology services. It specializes in immunomodulation as a therapeutic approach for CNS and oncology. The company was founded by Brian Paegel on July 12, 2017 and is headquartered in San Diego, CA. | 3 ans |
Chas Pulido | M | - |
Zafrens, Inc.
Zafrens, Inc. BiotechnologyHealth Technology Zafrens, Inc. is an American company that is pioneering an ultra-high throughput platform to isolate, culture, image, and sequence millions of cells per day. Zafrens is based in California. The proprietary platform allows for full characterization of diverse cell populations, as well as directly correlating molecular profiles (DNA, RNA, protein) to cell phenotype and function. The company's mission is to unlock the full story of every cell to accelerate drug discovery. The CEO of the company is Kandaswamy Vijayan. | 3 ans |
Wasim Malik | M | - |
Zafrens, Inc.
Zafrens, Inc. BiotechnologyHealth Technology Zafrens, Inc. is an American company that is pioneering an ultra-high throughput platform to isolate, culture, image, and sequence millions of cells per day. Zafrens is based in California. The proprietary platform allows for full characterization of diverse cell populations, as well as directly correlating molecular profiles (DNA, RNA, protein) to cell phenotype and function. The company's mission is to unlock the full story of every cell to accelerate drug discovery. The CEO of the company is Kandaswamy Vijayan. | 1 ans |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Kiersten Stead | M | - |
Plexium, Inc.
Plexium, Inc. Pharmaceuticals: MajorHealth Technology Plexium, Inc. provides drug development methodology services. It specializes in immunomodulation as a therapeutic approach for CNS and oncology. The company was founded by Brian Paegel on July 12, 2017 and is headquartered in San Diego, CA. | 4 ans |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 6 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- Kandaswamy Vijayan
- Réseau Personnel